Ben J A Janssen Selected Research

Hypertension (High Blood Pressure)

3/2014	Cardiac remodeling during and after renin-angiotensin system stimulation in Cyp1a1-Ren2 transgenic rats.
1/2014	Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice.
1/2013	Identification of free nitric oxide radicals in rat bone marrow: implications for progenitor cell mobilization in hypertension.
1/2013	Irreversible renal damage after transient renin-angiotensin system stimulation: involvement of an AT1-receptor mediated immune response.
11/2012	Impaired flow-induced arterial remodeling in DOCA-salt hypertensive rats.
9/2012	Dual neural endopeptidase/endothelin-converting [corrected] enzyme inhibition improves endothelial function in mesenteric resistance arteries of young spontaneously hypertensive rats.
1/2011	Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ben J A Janssen Research Topics

Disease

7	Hypertension (High Blood Pressure) 03/2014 - 01/2011
5	Inflammation (Inflammations) 02/2016 - 04/2008
5	Fibrosis (Cirrhosis) 01/2014 - 04/2008
4	Heart Failure 02/2012 - 03/2004
3	Infarction (Infarctions) 01/2019 - 10/2011
2	Atherosclerosis 02/2016 - 01/2015
2	Body Weight (Weight, Body) 01/2014 - 01/2007
2	Hypertrophy 01/2014 - 03/2007
2	Myocardial Infarction 10/2011 - 07/2005
2	Essential Hypertension 01/2011 - 01/2011
2	Cardiomegaly (Heart Hypertrophy) 04/2008 - 03/2007
1	Hypoxia (Hypoxemia) 02/2016
1	Diabetic Cardiomyopathies 07/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2010
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2008
1	Atrophy 12/2007
1	Respiratory Insufficiency (Respiratory Failure) 12/2004
1	Heart Rupture 09/2004
1	Sepsis (Septicemia) 10/2003
1	Hypotension (Low Blood Pressure) 10/2003
1	Shock 10/2003

Drug/Important Bio-Agent (IBA)

3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2016 - 10/2003
3	Endothelin-1 (Endothelin 1)IBA 11/2012 - 06/2010
2	Peptide FragmentsIBA 01/2019 - 10/2011
2	OsteopontinIBA 01/2014 - 01/2013
2	Angiotensin IIIBA 01/2014 - 09/2004
2	Advanced Glycation End ProductsIBA 01/2014 - 07/2013
2	Messenger RNA (mRNA)IBA 01/2014 - 01/2007
2	CollagenIBA 02/2012 - 12/2007
2	SphingolipidsIBA 01/2011 - 01/2011
2	CeramidesIBA 01/2011 - 01/2011
1	NitratesIBA 02/2016
1	NitritesIBA 02/2016
1	Drinking WaterIBA 02/2016
1	LDL Receptors (LDL Receptor)IBA 02/2016
1	CholesterolIBA 02/2016
1	Sodium Chloride FDA LinkGeneric 02/2016
1	sodium nitrateIBA 02/2016
1	perflexane (perfluorohexane)FDA Link 01/2015
1	ReninIBA 03/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	AMP-Activated Protein KinasesIBA 01/2014
1	AlbuminsIBA 01/2014
1	nephrinIBA 01/2014
1	EnzymesIBA 07/2013
1	Lactoylglutathione LyaseIBA 07/2013
1	Losartan (Cozaar)FDA LinkGeneric 01/2013
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2013
1	Desoxycorticosterone Acetate (DOCA)FDA Link 11/2012
1	Acetates (Acetic Acid Esters)FDA Link 11/2012
1	Desoxycorticosterone (Deoxycorticosterone)IBA 11/2012
1	SaltsIBA 11/2012
1	Peptides (Polypeptides)IBA 09/2012
1	Vasoconstrictor AgentsIBA 09/2012
1	Wnt ProteinsIBA 10/2011
1	Frizzled ReceptorsIBA 10/2011
1	cyclopamineIBA 08/2008
1	PPAR alphaIBA 04/2008
1	Spironolactone (Aldactone)FDA LinkGeneric 12/2007
1	Glycogen Synthase (Synthase I)IBA 03/2007
1	beta CateninIBA 03/2007
1	Transcription Factors (Transcription Factor)IBA 03/2007
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2007
1	ProteomeIBA 07/2005
1	Proteins (Proteins, Gene)FDA Link 07/2005
1	Atropine FDA LinkGeneric 12/2004
1	Adrenergic Agents (Adrenergic Drugs)IBA 03/2004

Therapy/Procedure

1	Therapeutics 10/2011